David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.36% |
| 2 | Consumer Discretionary | 9.47% |
| 3 | Financials | 6.95% |
| 4 | Healthcare | 6.38% |
| 5 | Communication Services | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Replimune Group
REPL
$1.49B
| $8.15M | 0.01% |
997,786
+754,780
| +311% | +$6.19M |
|
|
SKX
1402
DELISTED
Skechers
SKX
| $8.15M | 0.01% |
133,004
-171,568
| -56% | -$10.5M |
|
1403
CALL
TFI International
TFII
$11B
| $8.14M | 0.01% |
51,000
+9,000
| +21% | +$1.29M |
|
1404
CALL
TransDigm Group
TDG
$65.9B
| $8.13M | 0.01% |
6,600
| – | – |
|
1405
PUT
Darling Ingredients
DAR
$9.88B
| $8.1M | 0.01% |
174,200
+136,200
| +358% | +$6M |
|
1406
CALL
US Bancorp
USB
$97.2B
| $8.1M | 0.01% |
181,200
-148,800
| -45% | -$6.28M |
|
|
NETD
1407
DELISTED
Nabors Energy Transition Corp II
NETD
| $8.1M | 0.01% |
778,728
| – | – |
|
1408
CSX Corp
CSX
$95.4B
| $8.09M | 0.01% |
218,207
+111,918
| +105% | +$4.08M |
|
1409
CALL
Thomson Reuters
TRI
$45.2B
| $8.08M | 0.01% |
51,118
-25,520
| -33% | -$3.97M |
|
1410
Editas Medicine
EDIT
$504M
| $8.08M | 0.01% |
1,089,240
-98,324
| -8% | -$817K |
|
1411
Coursera
COUR
$1.64B
| $8.06M | 0.01% |
574,874
-330,501
| -37% | -$5.61M |
|
1412
MACOM Technology Solutions
MTSI
$20.3B
| $8.05M | 0.01% |
84,192
-105,012
| -56% | -$9.28M |
|
|
AAN
1413
DELISTED
The Aaron's Company Inc
AAN
| $8.03M | 0.01% |
1,071,302
-16,906
| -2% | -$158K |
|
1414
Cellebrite
CLBT
$2.83B
| $8.03M | 0.01% |
725,146
+254,038
| +54% | +$2.59M |
|
|
CFLT
1415
PUT
DELISTED
Confluent
CFLT
| $8.02M | 0.01% |
+262,900
| New | +$7.42M |
|
1416
Aurora
AUR
$11.6B
| $8.02M | 0.01% |
2,844,422
-254,893
| -8% | -$731K |
|
1417
PUT
Intuitive Surgical
ISRG
$131B
| $7.98M | 0.01% |
20,000
-30,000
| -60% | -$11.3M |
|
1418
CVS Health
CVS
$119B
| $7.97M | 0.01% |
99,919
-27,822
| -22% | -$2.13M |
|
|
DCPH
1419
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $7.97M | 0.01% |
506,384
+117,721
| +30% | +$1.81M |
|
1420
Bentley Systems
BSY
$11.1B
| $7.96M | 0.01% |
152,454
+136,840
| +876% | +$6.89M |
|
1421
RTX Corp
RTX
$283B
| $7.94M | 0.01% |
81,393
-22,407
| -22% | -$2.02M |
|
1422
CALL
Live Nation Entertainment
LYV
$43.5B
| $7.93M | 0.01% |
75,000
-40,000
| -35% | -$3.78M |
|
1423
Interactive Brokers
IBKR
$44.5B
| $7.93M | 0.01% |
283,820
-199,120
| -41% | -$4.96M |
|
1424
Mettler-Toledo International
MTD
$28.1B
| $7.92M | 0.01% |
5,948
-3,014
| -34% | -$3.72M |
|
1425
HubSpot
HUBS
$11.9B
| $7.9M | 0.01% |
12,603
-23,942
| -66% | -$14.4M |
|
Similar funds
David Shaw's Q1 2024 Portfolio in Review
As of Q1 2024, David Shaw held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
David Shaw withdrew a net $8.58B in Q1 2024, closing 634 positions and reducing 1,722 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $307M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in Arm worth $297M.
- David Shaw's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- David Shaw added most to Apple in Q1 2024, an estimated $820M increase.
- David Shaw's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- David Shaw fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- David Shaw's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- David Shaw opened 655 new positions and closed 634 in Q1 2024.
- David Shaw's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.